Table S2.
GO annotation significantly related to target genes
| Term | Count | P-value | Genes |
|---|---|---|---|
| Lymphangiogenesis | 3 | 0.0043 | PPP3CB, FLT4, BMPR2 |
| Transmembrane receptor protein serine/threonine kinase activity | 3 | 0.0069 | LTBP4, LTBP1, BMPR2 |
| Feeding behavior | 7 | 0.0078 | MCHR1, PPYR1, OPRD1, GLS, ASIP, PHF21A, IAPP |
| RNA polymerase II carboxy-terminal domain kinase activity | 3 | 0.0043 | GTF2H1, CDK9, GTF2H4 |
| Copper chaperone activity | 2 | 0.0077 | PARK7, CCS |
| Fatty acid elongation, saturated fatty acid | 2 | 0.0077 | ELOVL4, ELOVL6 |
| Fatty acid elongation | 3 | 0.0029 | ELOVL2, ELOVL4, ELOVL6 |
| Intracellular receptor signaling pathway | 13 | 0.0090 | ZNF536, CCNE1, DCBLD2, PGR, MAP3K7, GPR56, ITCH, NOD1, KANK2, THRA, PARK7, RXRB, DDX5 |
| Negative regulation of protein complex assembly | 7 | 0.0071 | THRA, HEY2, SPTAN1, MAP3K7, OPRD1, MAPRE1, PARK7 |
| Positive regulation of stress-activated MAPK cascade | 8 | 0.0064 | IL1A, FLT4, MAP3K10, TNFSF11, NOD1, HIPK2, MAP3K7, STK25 |
| Lymph vessel morphogenesis | 3 | 0.0059 | PPP3CB, FLT4, BMPR2 |
| Intrinsic apoptotic signaling pathway in response to hydrogen peroxide | 2 | 0.0077 | PARK7, STK25 |
| Paracrine signaling | 2 | 0.0077 | TNFSF11, PGR |
| Sertoli cell development | 3 | 0.0059 | DMRT1, ARID4B, SDC1 |
| Positive regulation of stress-activated protein kinase signaling cascade | 8 | 0.0067 | IL1A, FLT4, MAP3K10, TNFSF11, NOD1, HIPK2, MAP3K7, STK25 |
| Serine/threonine protein kinase complex | 5 | 0.0072 | GTF2H1, CDK9, MAP3K7, RB1CC1, GTF2H4 |
| Protein kinase complex | 7 | 0.0026 | GTF2H1, CDK9, CCNE1, PRKAB2, GTF2H4, MAP3K7, RB1CC1 |
Abbreviation: GO, gene ontology.